(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile | CAS:256431-72-8

We serve (E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile CAS:256431-72-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile

Chemical Name:(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile
CAS.NO:256431-72-8
Synonyms:(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile
Molecular Formula:C21H15FN2
Molecular Weight:314.35600
 
Physical and Chemical Properties:
Density:1.264
Boiling point:494.251ºC
Flash point:252.714ºC
Index of Refraction:1.686
 
Specification:
Appearance:Off-white or slight yellow crystalline powder
Assay:≥98.0%
Loss on drying:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of Rosuvastatin Calcium



Contact us for information like (E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile Use and application,(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile technical grade,usp/ep/jp grade.


Related News: It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.N,N'-Diphenylbenzidine manufacturer It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.1-benzyl-4-chloropiperidine supplier A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.5-Methyl-3-nitropyridin-2-amine vendor A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.